胰腺癌前期化疗用吉米西塔治疗胰腺癌导致缺乏症
Masahiro Iseki1, Masamichi Mizuma, Mitsuhiro Shimura
1From the Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Pancreas
|August 5, 2024
概括
在胰腺癌 (PC) 患者的手术前化疗显著降低了血清水平. 对接受化疗和胰腺切除术的患者来说,对和补充剂的监测至关重要.
科学领域:
- 在瘤学瘤学.
- 营养生物化学 营养生物化学
背景情况:
- 胰腺癌 (PC) 管理通常涉及新辅助化疗.
- 血清水平可能会受到各种治疗和疾病状态的影响.
研究的目的:
- 评估手术前化疗对胰腺癌患者血清度的影响.
- 分析不同化疗方案的水平变化.
主要方法:
- 在胰腺切除术前,测量了231名PC患者的血清度.
- 分析了患者数据,治疗过程和实验室结果.
- 在接受GEM + S1或GEM + nab-PTX的患者中,比较了化疗前和后的水平.
主要成果:
- 手术前的化疗导致血清度的统计显著下降 (79.3μg/dL vs 68.7μg/dL,P < 0.001).
- 这种减少在GEM + S1 (P = 0.019) 和GEM + nab-PTX (P < 0.001) 治疗方案中都得到了一致的观察.
- 135名患者接受了前置胰腺切除术,58人接受了GEM+S1,29人接受了手术前的GEM+nab-PTX.
结论:
- 手术前的化疗方案,包括GEM + S1和GEM + nab-PTX,在PC患者中持续降低血清水平.
- 对于接受新辅助化疗和胰腺切除术的PC患者,建议对血清的密切监测和及时补充.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
156
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
156
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
186
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
186


